Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.
作者信息
Behrends Czarina N, Nugent Ann V, Des Jarlais Don C, Frimpong Jemima A, Perlman David C, Schackman Bruce R
机构信息
Department of Healthcare Policy & Research, Weill Cornell Medical College, New York, NY.
Icahn School of Medicine at Mt. Sinai, New York, NY.
出版信息
J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e76-e78. doi: 10.1097/QAI.0000000000001792.
Abstract
摘要
相似文献
1
Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.美国注射器服务项目中艾滋病毒和丙型肝炎病毒现场检测与治疗的可及性
J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e76-e78. doi: 10.1097/QAI.0000000000001792.
2
Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.注射器交换项目中的人类免疫缺陷病毒和丙型肝炎病毒检测服务：可及性与结果
J Subst Abuse Treat. 2007 Jun;32(4):423-9. doi: 10.1016/j.jsat.2006.11.002. Epub 2007 Jan 9.
3
Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.在参与针具交换项目的原住民客户中，丙型肝炎病毒抗体的流行率更高。
Aust N Z J Public Health. 2011 Oct;35(5):421-6. doi: 10.1111/j.1753-6405.2011.00743.x. Epub 2011 Sep 12.
4
Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).全美历史最悠久的州级注射器交换项目的服务对象中丙型肝炎病毒（HCV）和人类免疫缺陷病毒（HIV）的感染血清流行率：社区卫生外展预防艾滋病（CHOW）工作的横断面研究。
Int J Drug Policy. 2017 Oct;48:34-43. doi: 10.1016/j.drugpo.2017.06.009. Epub 2017 Aug 2.
5
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.整合多种针对注射吸毒者丙型肝炎预防和护理的项目及政策方法：一种综合方法。
Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20.
6
Strategies to improve access to sterile syringes for injection drug users.改善注射吸毒者获取无菌注射器的策略。
AIDS Read. 2002 Dec;12(12):527-35.
7
Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.针头和注射器的合法获取/针头交换计划与艾滋病毒咨询和检测以预防艾滋病毒在静脉吸毒者中传播的比较：丹麦、挪威和瑞典的一项比较研究
Eur J Public Health. 2003 Sep;13(3):252-8. doi: 10.1093/eurpub/13.3.252.
8
Missed opportunities for hepatitis C testing in opioid treatment programs.阿片类药物治疗项目中丙型肝炎检测的错失机会。
Am J Public Health. 2013 Jun;103(6):1028-30. doi: 10.2105/AJPH.2012.301129. Epub 2013 Apr 18.
9
Syringe access programs.注射器获取项目。
J Assoc Nurses AIDS Care. 2012 May-Jun;23(3):272-4. doi: 10.1016/j.jana.2012.02.002.
10
An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.对针头交换和基于药房的项目进行经济分析，以提高注射吸毒者获得无菌注射器的机会。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32. doi: 10.1097/00042560-199802001-00021.
引用本文的文献
1
A systems analysis and improvement approach to optimizing syringe services programs' delivery of HIV testing and referrals: Study protocol for a parallel-group randomized controlled trial (SAIA-SSP-HIV).一种优化注射器服务项目中艾滋病毒检测与转诊服务提供的系统分析与改进方法：平行组随机对照试验（SAIA-SSP-HIV）的研究方案
PLoS One. 2025 Feb 25;20(2):e0319340. doi: 10.1371/journal.pone.0319340. eCollection 2025.
2
Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative.美国农村地区吸毒者中的无家可归现象：全国农村阿片类药物倡议的结果
Drug Alcohol Depend. 2025 Jan 1;266:112498. doi: 10.1016/j.drugalcdep.2024.112498. Epub 2024 Nov 14.
3
Considerations when prescribing opioid agonist therapies for people living with HIV.为 HIV 感染者开具阿片类激动剂治疗药物时的注意事项。
Expert Rev Clin Pharmacol. 2024 Jul;17(7):549-564. doi: 10.1080/17512433.2024.2375448. Epub 2024 Jul 4.
4
Past-Year HIV Testing, Current Antiretroviral Therapy Use, and Participation in Services for People Who Inject Drugs.过去一年的 HIV 检测、当前抗逆转录病毒治疗的使用情况，以及注射毒品者服务的参与情况。
AIDS Behav. 2024 Aug;28(8):2793-2803. doi: 10.1007/s10461-024-04369-0. Epub 2024 Jun 1.
5
NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service program.接下来：一种新型的基于互联网的邮寄注射器服务项目的描述、原理及评估。
J Subst Use. 2024;29(1):129-135. doi: 10.1080/14659891.2022.2144500. Epub 2022 Nov 11.
6
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder.在全国接受阿片类药物使用障碍治疗的个体样本中，药物准备、与注射相关的感染和减少伤害的做法。
Harm Reduct J. 2024 Jan 19;21(1):16. doi: 10.1186/s12954-024-00939-6.
7
Evaluation of self-directed specimen collection for chlamydia and gonorrhea testing among people who use drugs.评估吸毒人群自我采集样本进行衣原体和淋病检测。
Int J STD AIDS. 2024 Mar;35(3):217-227. doi: 10.1177/09564624231215859. Epub 2023 Nov 16.
8
Differential risks of syringe service program participants in Central Ohio: a latent class analysis.俄亥俄州中部的注射服务项目参与者的差异风险：潜在类别分析。
Harm Reduct J. 2023 Jul 28;20(1):97. doi: 10.1186/s12954-023-00824-8.
9
Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial.在注射器服务项目中提供同址丙型肝炎治疗的成本超过了潜在报销额度：一项临床试验的结果。
Drug Alcohol Depend Rep. 2022 Dec;5. doi: 10.1016/j.dadr.2022.100109. Epub 2022 Oct 7.
10
Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey.2021 年 6 月至 8 月美国注射毒品者服务项目中的疫苗接种障碍和机会：一项横断面调查。
Drug Alcohol Depend. 2022 Aug 1;237:109540. doi: 10.1016/j.drugalcdep.2022.109540. Epub 2022 Jun 16.
本文引用的文献
1
Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic.注射吸毒者中的丙型肝炎——阿片类药物流行的一个隐藏危险。
N Engl J Med. 2018 Mar 29;378(13):1169-1171. doi: 10.1056/NEJMp1716871.
2
Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.2004 年至 2014 年美国与阿片类药物流行及相关注射吸毒相关的急性丙型肝炎病毒感染增加。
Am J Public Health. 2018 Feb;108(2):175-181. doi: 10.2105/AJPH.2017.304132. Epub 2017 Dec 21.
3
US Health Care Reform and Rural America: Results From the ACA's Medicaid Expansions.美国医疗保健改革与美国农村：ACA 医疗补助扩张的结果。
J Rural Health. 2018 Mar;34(2):213-222. doi: 10.1111/jrh.12284. Epub 2017 Nov 6.
4
Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.2005 - 2012年纽约市注射吸毒者中艾滋病毒和丙型肝炎病毒风险行为及现患感染趋势
J Acquir Immune Defic Syndr. 2017 Jul 1;75 Suppl 3(Suppl 3):S325-S332. doi: 10.1097/QAI.0000000000001407.
5
Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.马萨诸塞州注射器交换项目客户获得医疗保险和医疗服务的情况：来自“我愿意”关爱协作组织健康导航员的定性研究结果
Harm Reduct J. 2017 May 18;14(1):26. doi: 10.1186/s12954-017-0151-4.
6
Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization.种族和少数民族吸毒者所感受到的歧视及其与医疗保健利用的关联。
J Ethn Subst Abuse. 2017 Oct-Dec;16(4):404-419. doi: 10.1080/15332640.2017.1292418. Epub 2017 Mar 17.
7
Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.生命体征：美国注射吸毒者中的艾滋病毒诊断、风险行为和预防趋势。
MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1336-1342. doi: 10.15585/mmwr.mm6547e1.
8
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.2003 - 2013年美国丙型肝炎病毒相关死亡率上升
Clin Infect Dis. 2016 May 15;62(10):1287-1288. doi: 10.1093/cid/ciw111. Epub 2016 Mar 1.
9
Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014.2005 - 2014年纽约市注射吸毒者中极低艾滋病毒发病率的一致估计数
Am J Public Health. 2016 Mar;106(3):503-8. doi: 10.2105/AJPH.2015.303019. Epub 2016 Jan 21.
10
Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.为城市、城乡和农村地区注射毒品者提供的注射器服务计划-美国，2013 年。
MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1337-41. doi: 10.15585/mmwr.mm6448a3.
Zotero 插件